Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma von SIEGEL, Abby B, COHEN, Emil I, CHRISTOS, Paul, MAZUMDAR, Madhu, POPA, Elizabeta, BROWN, Robert S, RAFII, Shahin, SCHWARTZ, Jonathan D, OCEAN, Allyson, LEHRER, Deborah, GOLDENBERG, Alec, KNOX, Jennifer J, CHEN, Helen, CLARK-GARVEY, Sean, WEINBERG, Alan, MANDELI, John

Volltext

Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations von He, A. Ruth, Goldenberg, Alec S.

Volltext

Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: observations from a US regional analysis of the GIDEON registry von Martin, Robert CG., MD PhD, Bruenderman, Elizabeth, BS, Cohn, Allen, MD, Piperdi, Bilal, MD, Miksad, Rebecca, MD, Geschwind, Jean-Francois, MD, Goldenberg, Alec, MD, Sanyal, Arun, MD, Zigmont, Ellen, D, Pharm, Babajanyan, Svetlana, MS, MD, Foreman, Pamela, PhD, Mantry, Parvez, MD, McGuire, Brendan, MD, Gholam, Pierre, MD

Volltext

Chronic Thalidomide and Chemoembolization for Hepatocellular Carcinoma von Wu, Jennifer, Ng, Jennifer, Christos, Paul J., Goldenberg, Alec S., Sparano, Joseph, Sung, Max W., Hochster, Howard S., Muggia, Franco M.

Volltext

Central Venous Catheter Placement in Patients With Disorders of Hemostasis von Doerfler, Martin E., Kaufman, Brian, Goldenberg, Alec S.

Volltext

Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL) von Lee, Hun Ju, Choi, Michael Y., Siddiqi, Tanya, Rhodes, Joanna M., Wierda, William G., Isufi, Iris, Tuscano, Joseph M, Lamanna, Nicole, Subbiah, Suki, Koff, Jean L., Leslie, Lori, Goldenberg, Alec, Chung, Gina G, Breitmeyer, James B., Yazji, Salim, Wang, Michael, Jamieson, Catriona, Kipps, Thomas J.

Volltext

Phase 1/2 study of zilovertamab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) von Lee, Hun Ju, Choi, Michael Y., Siddiqi, Tanya, Rhodes, Joanna Meehan, Wierda, William G., Isufi, Iris, Tuscano, Joseph M., Lamanna, Nicole, Subbiah, Suki, Koff, Jean Louise, Leslie, Lori Ann, Goldenberg, Alec, Chung, Gina G., Yazji, Salim, Wang, Yao, Breitmeyer, James Bradley, Wang, Michael, Jamieson, Catriona, Kipps, Thomas J.

Volltext

Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) von Lee, Hun Ju, Choi, Michael, Siddiqi, Tanya, Barrientos, Jacqueline, Wierda, William G., Isufi, Iris, Tuscano, Joseph, Lamanna, Nicole, Subbiah, Suki, Koff, Jean L., Leslie, Lori A., Goldenberg, Alec, Chung, Gina G, Breitmeyer, James B., Yazji, Salim, Wang, Yao, Wang, Michael, Jamieson, Catriona, Kipps, Thomas J.

Volltext

Phase 1/2 study of cirmtuzumab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) von Lee, Hun Ju, Choi, Michael Y., Siddiqi, Tanya, Barrientos, Jacqueline Claudia, Wierda, William G., Isufi, Iris, Tuscano, Joseph M., Lamanna, Nicole, Subbiah, Suki, Koff, Jean Louise, Leslie, Lori Ann, Goldenberg, Alec, Chung, Gina G., Breitmeyer, James Bradley, Hsu, Frank J., Wang, Michael, Jamieson, Catriona, Kipps, Thomas J.

Volltext

Non-Hodgkin's lymphoma presenting as a breast mass in patients with HIV infection: A report of three cases von Chanan-Khan, Asher, Holkova, Beata, Goldenberg, Alec S, Pavlick, Anna, Demopoulos, Rita, Takeshita, Kenichi

Volltext

Cirmtuzumab, an Anti-ROR1 Antibody, in Combination with Ibrutinib: Clinical Activity in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) from a Phase 1/2 Study von Lee, Hun Ju, Choi, Michael Y., Siddiqi, Tanya, Wierda, William G., Barrientos, Jacqueline C., Lamanna, Nicole, Goldenberg, Alec, Isufi, Iris, Tuscano, Joseph, Subbiah, Suki, Koff, Jean L., Leslie, Lori A., Chung, Gina G, Weihe, Elizabeth K, Ianopulos, Xen, Breitmeyer, James B., Hsu, Frank J, Wang, Michael, Jamieson, Catriona, Kipps, Thomas J.

Volltext

Clinical activity of cirmtuzumab, an anti-ROR1 antibody, in combination with ibrutinib: Interim results of a phase Ib/II study in mantle cell lymphoma (MCL) or chronic lymphocytic... von Lee, Hun Ju, Choi, Michael Y., Siddiqi, Tanya, Wierda, William G., Barrientos, Jacqueline Claudia, Lamanna, Nicole, Goldenberg, Alec, Isufi, Iris, Tuscano, Joseph M., Subbiah, Suki, Weihe, Elizabeth Kristine, Ianopulos, Xen, Breitmeyer, James Bradley, Hsu, Frank J., Wang, Michael, Jamieson, Catriona HM, Kipps, Thomas J.

Volltext

Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for CLL and MCL von Choi, Michael Y., Ghia, Emanuela M., Siddiqi, Tanya, Wierda, William G., Lee, Hun Ju, Barrientos, Jacqueline C., Lamanna, Nicole, Goldenberg, Alec, Tzachanis, Dimitrios, Reid, Erin G., Weihe, Elizabeth K, Rassenti, Laura Z., Isufi, Iris, Bieler, Stewart, Ianopulos, Xen, Breitmeyer, James B., Jamieson, Catriona, Kipps, Thomas J.

Volltext

Clinical experience with a new specimen capturing bone marrow biopsy needle von Goldenberg, Alec S., Tiesinga, James J.

Volltext

A phase II/III, multicenter, open-label, 3-arm study of gilteritinib, gilteritinib plus azacitidine, or azacitidine alone in the treatment of newly diagnosed FLT3 mutation-positive... von Cortes, Jorge E., Altman, Jessica, Ritchie, Ellen K., Larson, Richard A., Claxton, David, Minden, Mark D., Goldenberg, Alec, Naoe, Tomoki, Yoon, Sung-Soo, Rousselot, Philippe H., Mueller-Tidow, Carsten, del Castillo, Teresa Bernal, Havelange, Violaine, Ciceri, Fabio, Knopinska-Posluszny, Wanda, Liu, Shufang, Shrivastava, Archita, James, Angela Joubert, Rich, Elizabeth Shima, Bahceci, Erkut

Volltext

Potential factors influencing initial sorafenib dose selection in hepatocellular carcinoma (HCC): U.S. regional analysis of GIDEON von Piperdi, Bilal, Cohn, Allen Lee, El-Khoueiry, Anthony B., Geschwind, Jean-Francois, Gholam, Pierre Michel, Mantry, Parvez, Martin, Robert C. G., McGuire, Brendan, Miksad, Rebecca A., Sanyal, Arun J., Venook, Alan Paul, Babajanyan, Svetlana, Goldenberg, Alec

Volltext

Use of staging and scoring systems in hepatocellular carcinoma (HCC): Lessons from U.S. regional analysis of the GIDEON registry von Miksad, Rebecca A., Cohn, Allen Lee, El-Khoueiry, Anthony B., Geschwind, Jean-Francois, Gholam, Pierre Michel, Goldenberg, Alec, Mantry, Parvez, Martin, Robert C. G., McGuire, Brendan, Piperdi, Bilal, Sanyal, Arun J., Imperial, Joanne, Venook, Alan Paul

Volltext

Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry von Geschwind, Jean-Francois H., Gholam, Pierre M., Goldenberg, Alec, Mantry, Parvez, Martin, Robert C. G., Piperdi, Bilal, Zigmont, Ellen, Imperial, Joanne, Babajanyan, Svetlana, Foreman, Pamela K., Cohn, Allen

Volltext

Second interim analysis of Global Investigation of Therapeutic Decisions in Unresectable HCC and of its Treatment with Sorafenib (GIDEON): U.S. versus global perspective on patient... von Goldenberg, Alec, El-Khoueiry, Anthony B., Martin, Robert C. G., Venook, Alan Paul, Mantry, Parvez, Gholam, Pierre Michel, McGuire, Brendan, Sanyal, Arun, Geschwind, Jean-Francois, Marrero, Jorge A.

Volltext

Tu1609 Sorafenib Use After Prior Surgical Resection or Transplant in Hepatocellular Carcinoma: US Regional Analysis of GIDEON von Martin, Robert C, Cohn, Allen, Geschwind, Jean-Francois, Goldenberg, Alec, Mantry, Parvez S, McGuire, Brendan M, Miksad, Rebecca, Piperdi, Bilal, Sanyal, Arun J, Venook, Alan, Zigmont, Ellen, Gholam, Pierre M

Volltext